ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 98

The Mitochondrial DNA (mtDNA) Haplogroups Influence the Risk of Incidence Knee OA. Replication Study Including Data from Check and OAI Cohorts

Ignacio Rego-Pérez1, Angel Soto-Hermida1, Juan Fernandez-Tajes1, Mercedes Fernandez Moreno1, Maria Eugenia Vazquez Mosquera1, Estefanía Cortés-Pereira1, Sonia Pertega2, Sara Relaño-Fernandez1, Natividad Oreiro1, Carlos Fernandez-Lopez1 and Francisco J. Blanco1, 1Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain, 2Unidad de Epidemiología Clínica y Bioestadística. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC), A Coruña, Spain

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Genetic Biomarkers, Mitochondria, osteoarthritis and radiography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Genetics, Genomics and Proteomics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Previous studies showed a significant influence of the mtDNA haplogroups on prevalence, radiographic progression and cartilage integrity of knee OA patients from different worldwide cohorts. The aim of this study is to analyze the influence of the mitochondrial variants on the risk of incident knee OA in patients from CHECK as well as in an updated cohort of OAI patients.

Methods:

We assessed the mtDNA haplogroups in 1003 DNA samples from CHECK and 3681 Caucasian samples from the OAI. Incident knee OA was defined as a KL score <2 at baseline and a KL≥2 during 8 (CHECK) and 4 (OAI) years follow-up. Patients suitable for incident knee OA study (KL≤1 at baseline) consisted in 768 and 2409 respectively. Statistical analyses included chi-square contingency tables and logistic regression models considering age, gender, body mass index (BMI), bilateral KL=1 (CHECK) or contralateral knee OA (OAI) at baseline and mtDNA variants as variables of interest.

Results:

After 8 and 4 years respectively, patients from CHECK had more radiographic change compared with the OAI group (p<0,001) so that 418 (54,4%) patients from CHECK and 326 (13,5%) patients from OAI underwent incident knee OA. Patients carrying the haplogroups of the mitochondrial cluster TJ were significantly underrepresented in the incident knee OA group of both cohorts when compared with the most common mtDNA haplogroup H/HV (OR=0,598; CI=0,357-0,999; p=0.05 for the CHECK cohort and OR=0,658; CI=0,467-0,927; p=0.017 for the OAI cohort). In addition, bilateral KL=1 at baseline in the CHECK cohort and contralateral knee OA in the OAI cohort were risk factors to develop incident knee OA (p<0,001). For both cohorts BMI was a risk factor too (p=0,023 and p<0,001 respectively) (Tables 1 and 2). The AUC of the regression models ranged from 0,643 to 0,688.

Conclusion:

The mitochondrial genome contributes to the development of incident knee OA in two well-defined follow-up cohorts, one of them an early-stage OA cohort (CHECK). The assignment of the mitochondrial polymorphisms common to the major mtDNA clusters could be used as complementary genetic biomarkers to predict the risk of incident knee OA.

Table 1. Percentage of OA patients from the CHECK cohort that underwent incident knee OA during 8 years follow-up according to mtDNA haplogroups and results of the regression model

Variables

N (% Incidents)

OR

95% CI

p-value

Gender (female)

1,204

0,823-1,759

0,339

Age

1,025

0,995-1,056

0,107

BMI

1,047

1,006-1,089

0,023*

Bilateral KL=1 at baseline

4,943

3,347-7,301

<0,001*

mtDNA haplogroups

H (n=320)

181 (56,6%)

1

–

–

Uk (n=176)

97 (55.1%)

0,963

0,647-1,434

0,855

J (n=65)

35 (53,8%)

0,966

0,541-1,724

0,906

T (n=87)

39 (44,8%)

0,598

0,357-0,999

0,050*

Others (n=120)

66 (55,0%)

0,939

0,595-1,481

0,787

KL: Kellgren and Lawrence; mtDNA: mitochondrial DNA; OR: odd ratio; CI: confidence interval; BMI: body mass index; (*): statistical significance declared at p≤0.05 (the most common mtDNA haplogroup H was used as reference group)

Table 2. Percentage of OA patients from the OAI cohort that underwent incident knee OA during 4 years follow-up according to mtDNA clusters and results of the regression model

Variables

N (% Incidents)

OR

95% CI

p-value

Gender (female)

1,540

1,205-1,968

0,001*

Age

1,003

0,990-1,016

0,682

BMI

1,068

1,040-1,096

<0,001*

Contralateral (KL≥2) OA at baseline

1,830

1,434-2,336

<0,001*

mtDNA clusters

HV (n=1123)

168 (15,0%)

1

–

–

KU (n=565)

78 (13,8%)

0,920

0,684-1,237

0,581

TJ (n=471)

50 (10,6%)

0,658

0,467-0,927

0,017*

Others (n=250)

30 (12,0%)

0,793

0,518-1,215

0,287

KL: Kellgren and Lawrence; mtDNA: mitochondrial DNA; OR: odd ratio; CI: confidence interval; BMI: body mass index; (*): statistical significance declared at p≤0.05 (the most common mtDNA cluster HV was used as reference group)


Disclosure: I. Rego-Pérez, None; A. Soto-Hermida, None; J. Fernandez-Tajes, None; M. Fernandez Moreno, None; M. E. Vazquez Mosquera, None; E. Cortés-Pereira, None; S. Pertega, None; S. Relaño-Fernandez, None; N. Oreiro, None; C. Fernandez-Lopez, None; F. J. Blanco, Pfizer, Bioiberica, and Gebro Pharma, 5.

To cite this abstract in AMA style:

Rego-Pérez I, Soto-Hermida A, Fernandez-Tajes J, Fernandez Moreno M, Vazquez Mosquera ME, Cortés-Pereira E, Pertega S, Relaño-Fernandez S, Oreiro N, Fernandez-Lopez C, Blanco FJ. The Mitochondrial DNA (mtDNA) Haplogroups Influence the Risk of Incidence Knee OA. Replication Study Including Data from Check and OAI Cohorts [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-mitochondrial-dna-mtdna-haplogroups-influence-the-risk-of-incidence-knee-oa-replication-study-including-data-from-check-and-oai-cohorts/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-mitochondrial-dna-mtdna-haplogroups-influence-the-risk-of-incidence-knee-oa-replication-study-including-data-from-check-and-oai-cohorts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology